-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The new round of national medical insurance drug negotiations at the end of 2020 has achieved remarkable results.
A total of 119 drugs have finally been successfully negotiated.
The number has hit a new high in recent years, and the price has fallen sharply.
The author believes that the phenomenon of "difficulty in entering the hospital" is a product of deepening the reform of the medical insurance drug catalogue management, and its emergence is inevitable.
Reform itself is a systematic project involving multiple parties, and it is also a process of constantly discovering and solving problems.
The difficulty of landing requires a linkage between medical care, medical insurance, and pharmaceutical reforms to eliminate various obstacles, and finally deliver the negotiated drugs to the patients, and effectively enhance the patients' sense of the benefits of the medical reform.